To emphasize the effectiveness of using esophagoduodenal megastents for treating acute gastric leaks post-laparoscopic sleeve gastrectomy.
Key Findings:
Acute/early gastric leaks have a mortality rate of 0.2 to 3.7%, rising to 35% with severe sepsis.
Megastents demonstrate a success rate exceeding 90%, significantly higher than conventional stents.
Stent migrations occurred in 30% of cases but were managed without severe clinical consequences.
Interpretation:
Rapid and effective management of acute gastric leaks is crucial to prevent severe complications, and megastents provide a superior treatment option.
Limitations:
Meta-analyses referenced include both acute and chronic leaks, limiting generalizability.
Included studies may suffer from small sample sizes and publication bias.
Conclusion:
For acute/early gastric leaks, the use of megastents is recommended for their high efficacy and straightforward application, reinforcing the notion that 'the bigger, the better.'
